Profile image
Story Views

Last Hour:
Last 24 Hours:

Bone Marrow Transplant Market by Region & Data Validation, Analysis and Forecast 2022

Thursday, January 12, 2017 23:37
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Bone Marrow Transplant market accounted for $10.58 billion in 2015 and is expected to reach $15.95 billion by 2022 growing at a CAGR of 6.0% from 2015 to 2022. Occurrence of blood cancers and increasing investment in logistic services are the key factors fueling the market growth. On the other hand, high cost of the treatment and uncertainty of reimbursement in several developing countries are the key factors hampering the market growth.

With more than 60% of the total market share in 2014, Autologous segment leads the global bone marrow transplant market due to the less considerable side effects. Allogeneic is anticipated to grow at the highest CAGR during the forecast period. Europe dominated the global market for bone marrow transplant accounting for more than 50% of the market revenue followed by North America.

 For more information

Some of the key players in the market include Lonza Group Ltd., Cellular Dynamics International, Merck Millipore Corporation, ABM Industries, Inc., HemaCare Corporation, ReachBio LLC, American Type Culture Collection (ATCC) Inc., Conversant Biologics, Inc., PromoCell GmbH, Sanofi-Aventis LLC, AllCells, LLC, Mesoblast Limited, STEMCELL Technologies Inc. and Lifeline Cell Technology.

Disease Indication Covered:
-Blood Cancer
-Myelodysplastic Syndrome 
-Solid Tumors 
-Myeloproliferative Neoplasms 
-Blood Disorders 
-Sickle cell anemia 
-Aplastic anemia 

Transplant Type Covered:
-Allogeneic Bone Marrow Transplant
-Autologous Bone Marrow Transplant

End Users Covered:
-Multispecialty Clinics
-Ambulatory Surgery Centers

Regions Covered:
-North America
-Rest of Europe 
-Asia Pacific
-New Zealand 
-Rest of Asia Pacific
-Rest of the World
-Middle East
-South Africa

Request Sample Copy

10 Company Profiling 
10.1 Lonza Group Ltd. 
10.2 Cellular Dynamics International
10.3 Merck Millipore Corporation 
10.4 ABM Industries, Inc. 
10.5 HemaCare Corporation 
10.6 ReachBio LLC 
10.7 American Type Culture Collection (ATCC) Inc.
10.8 Conversant Biologics, Inc. 
10.9 PromoCell GmbH 
10.10 Sanofi-Aventis LLC 
10.11 AllCells, LLC 
10.12 Mesoblast Limited 
10.13 STEMCELL Technologies Inc. 
10.14 Lifeline Cell Technology 

Make an enquiry:

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.